Talk:Perindopril
Add topicLatest comment: 1 year ago by 5.173.162.50 in topic Advertising header
| This is the talk page for discussing improvements to the Perindopril article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1Auto-archiving period: 3 months  |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Perindopril.
|
erbumine
[edit]What is erbumine? 115.64.142.162 (talk) 00:50, 9 June 2016 (UTC)
- On the erbumine article is a description that "tert-butylamine (erbumine) has been used as a counterion in drug substances such as perindopril erbumine", i.e., to make the perindopril tablet more stable for dispensing and storage. Zefr (talk) 20:57, 28 March 2025 (UTC)
Advertising header
[edit]IP user 5.173.162.50 has made 3 edits to place an advertising header at the top of the article. Perindopril has different trade names in different countries, as noted in the article and as occurs for nearly every drug article on Wikipedia.
There appears to be no article information that hints of advertising, as the details provided are common for Wikipedia articles in drugs. Special:Diff/1282822981 represents revisions to better clarify and source.
Otherwise, it's not evident why the IP user thinks the article is advertising. The place to discuss it is here, rather than by edit-warring, WP:WAR. Leaving a note on the IP user's talk page. Zefr (talk) 20:50, 28 March 2025 (UTC)
- An encyclopedia used to advertise commercial products should not be called Wikipedia but Wokepedia. In a real encyclopedia there would be a description of the active substance, a list of studies on this compound, a written statement about who is responsible for inventing this compound and zero brands until the last paragraph, where all available brands of this product would be listed. I see no justification for advertising Coversum/Coversyl etc. in this article in the FOURTH PARAGRAPH of the article. You are servants of big pharma and specific companies, since the appropriate place to promote a specific drug (and not the active substance) is in the second paragraph of the "article" (advertisement). So I am removing Coversum/Coversyl from the second paragraph and moving it to the last section of brands, where it belongs.
- The article should not suggest to the doctor what drug to prescribe to the patient! — Preceding unsigned comment added by 5.173.162.50 (talk) 23:33, 28 March 2025 (UTC)